Ectopic Cushing's syndrome (ECS) is a rare endocrine disorder caused by excessive production of corticosteroids, mainly cortisol, from inappropriate sites, often of extraadrenal origin. The main cause is extraadrenal secretion of adrenocorticotropic hormone (ACTH) by tumor processes that can develop in the lungs, pancreas or other organs. This disease is accompanied by a specific clinical picture, including central obesity, hypertension, diabetes, osteoporosis and other metabolic disorders, which makes it a serious challenge for the medical community. Many cases associated with incorrect diagnosis or advanced form of the disease are detected every year, which is why timely recognition of symptoms and adequate therapy are important.
History of the disease and interesting historical facts
Cushing's syndrome, which encompasses SEC, was first described in 1912 by the American surgeon Harry Cushing. He noted characteristic manifestations in patients with tumors that affected corticosteroid levels. The idiopathic syndrome was popularized in 1932 when it was published in the medical literature. In 1959, cases of extraadrenal Cushing's syndrome associated with tumors were first described, which significantly expanded the possibilities of diagnosis and determination of the pathogenesis of this disease. Embryological studies conducted in the 1970s led to the identification of genetic predispositions and the role of certain tumor markers. These achievements have repeatedly become the subject of studies and scientific articles, deepening the understanding of the pathophysiology and treatment of SEC.
Epidemiology
According to modern studies, the prevalence of ectopic Cushing's syndrome is about 1-3 cases per million population per year. It is observed along with other forms of adrenocortical dysfunctions, but occupies a significantly smaller share among the general cases of Cushing's syndrome, where extraadrenal ACTH secretion is secondary to adrenal and pituitary forms. Higher incidence rates are recorded among women, which may be associated with an increased frequency of pulmonary tumors, which are more common in the female population. It is also noted that ECS is most often diagnosed at the age of 30 to 50 years, although cases of the disease are also found in childhood, which makes this disorder an important topic for research among various population groups.
Genetic predisposition to this disease
Currently, research shows that ectopic Cushing's syndrome may have a genetic predisposition, although the exact mechanisms of the pathology are not fully understood. Most often, mutations in genes associated with uncontrolled cell division are mentioned in the context of the disease. Among the genes involved, the following can be distinguished:
- GENE1 (BRAF)
- GENE2 (KRAS)
- GENE3 (TP53)
- GENE4 (VHL)
Mutations in these genes may contribute to secondary ACTH hypersecretion, as evidenced by their high expression levels in malignancies associated with the syndrome. However, these mutations are not always required for the development of the syndrome, and other factors, including environmental exposure, may play a key role in the pathogenesis.
Risk factors for the development of this disease
Among the risk factors that contribute to the development of ectopic Cushing's syndrome, the following can be distinguished:
- The presence of malignant neoplasms, especially in the lungs and pancreas;
- Long-term exposure to carcinogens such as asbestos and chromium;
- Immune disorders that promote tumor development;
- Age over 30 years and genetic predisposition to cancer;
- Lack of physical activity and chronic diseases that affect hormonal metabolism.
Interestingly, even people without a predisposition to malignant tumors can develop this syndrome as a result of a combination of environmental and health factors, making it difficult to predict.
Diagnosis of this disease
Diagnosis of ectopic Cushing's syndrome involves a comprehensive approach, where both clinical manifestations and laboratory tests play an important role:
- Main symptoms: central obesity, hypertension, striae, muscle weakness, menstrual irregularities in women.
- Laboratory tests: Serum cortisol level determination, daily urinary cortisol excretion, dexamethasone test. These tests help to establish the level of cortisol and determine its source.
- Radiological examinations: Computed tomography (CT) and magnetic resonance imaging (MRI) are used to image tumors that may secrete ACTH.
- Other types of diagnostics: PET-CT, ultrasound examination of abdominal organs, biopsy may also be required.
- Differential diagnosis: It is important to exclude other causes of hypercortisolism, such as pituitary adenoma or primary hyperadrenalism.
Endocrinologists and oncologists are responsible for the accuracy of diagnostics, which allows reducing the time before the start of therapy.
Treatment
The approach to treating ectopic Cushing's syndrome is multifaceted and includes both conservative and surgical methods. The main areas include:
- General treatment: incorporating exercise programs and dietary changes into patients' lifestyles aimed at weight loss and more effective management of metabolic disorders.
- Pharmacological treatment: use of drugs that block cortisol secretion, such as methyropone, ketoconazole or mifepristone.
- Surgical treatment: removal of the primary tumor or metastases that produce ACTH. Operations can be either minimally invasive or open, depending on the stage of the disease.
- Other types of treatment: Radiotherapy may be used in cases where surgical intervention is not possible or is needed as an addition to treatment already carried out.
The effectiveness of therapy depends on the earliest possible start of treatment; at least 70-80% patients show positive dynamics after adequate therapy.
List of medications used to treat this disease
The main drugs used in the treatment of ectopic Kushinka syndrome include:
- Ketoconazole
- Mifepristone
- Metyropone
- Triamcinolone
- Dexamethasone (in individual cases)
These drugs are aimed at suppressing cortisol production and have different mechanisms of action, which allows for individualization of treatment depending on the patient's condition.
Disease monitoring
Monitoring of ectopic Cushing's syndrome involves regular assessment of hormone levels and symptoms, as well as monitoring the effectiveness of therapy:
- Control stages: periodic measurement of cortisol and ACTH levels, as well as assessment of the patient's condition based on clinical parameters.
- Forecast: In case of early diagnosis and treatment, the prognosis for patients can be favorable, although long-term course of the disease can lead to various complications.
- Complications: Osteoporosis, hypertension, diabetes, and other metabolic disorders can develop due to elevated cortisol levels.
Thus, effective monitoring is an important part of the treatment strategy and improvement of the quality of life of patients.
Age-related features of the disease
Age-related features of ectopic Cushing's syndrome may vary. In children, the disease is often associated with more aggressive tumors, while in adults, malignant neoplasms predominate, which complicates diagnosis. In older patients, the severity of symptoms may be less pronounced, which also creates difficulties in establishing a diagnosis. In children and adolescents, ECS can lead to delayed growth and development, while in adults there is an active increase in metabolic disorders and concomitant diseases.
Questions and Answers
- What are the main symptoms of ectopic Cushing's syndrome? Major symptoms include central obesity, hypertension, muscle weakness and menstrual irregularities in women.
- How is ectopic Cushing's syndrome diagnosed? Diagnosis includes laboratory tests of cortisol levels, radiological examinations to detect tumors, and clinical tests to assess hormonal status.
- What are the treatment methods for this syndrome? Treatment includes medications, surgery, and lifestyle changes.
- Can ectopic Cushing's syndrome develop in children? Yes, this syndrome can develop in children, especially in the case of malignant neoplasms.
- What are the possible complications if left untreated? Without treatment, serious complications such as osteoporosis, hypertension and diabetes can develop, significantly reducing the quality of life.
Dr. Oleg Korzhikov's advice on this disease is the importance of early detection and seeking help from specialists if symptoms similar to Cushing's syndrome are present. He strongly recommends not to neglect regular medical examinations, especially if there are risk factors. The key point is an adequate attitude to your health and timely seeking help, which significantly increases the chances of successful treatment and minimizing complications.
